Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,519.12
(
0.61%
)
US TECH 100
29,229.20
(
1.84%
)
Dow Jones
50,461.68
(
-0.23%
)
Brent Oil
95.69
(
-1.34%
)
Bitcoin
75,779.54
(
-0.09%
)
News Focus
News Focus
Post# of 257644
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123024
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: genisi post# 98840

Wednesday, 04/25/2012 6:48:01 PM

Wednesday, April 25, 2012 6:48:01 PM

Post# of 257644
Effient logged 1Q12 sales of $116M (+106% YoY), of which $90M came from the US:

http://finance.yahoo.com/news/lilly-reports-solid-start-first-103000996.html

Clearly, Effient will never be a huge-selling drug, but it’s turning out to be less of a dog than some of us thought.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today